Rajeev K. Sahoo
Raurkela, OR 769008, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Soft Magnetism Meets Self-Assembly: Molecularly Engineered Magnetic Ionic Liquid Nanomicelles for the Solubilization, Sustained Release, and Anticancer Activity of Quercetin.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: April 29, 2026
Exosomal heterogeneity and functional zonation in cancer drug resistance.
Journal: Drug discovery today
Published: September 07, 2025
Integrative computational and experimental validation of Piperlongumine as a therapeutic agent targeting differentially expressed genes in colorectal cancer.
Journal: Pathology, research and practice
Published: July 03, 2025
Piperlongumine Triggers Reactive Oxygen Species Driven Mitochondrial Dysfunction Leading to Apoptosis in Human Colon Cancer Cells.
Journal: BioFactors (Oxford, England)
Published: December 21, 2024
Antihypertensive potential of diosgenin: A comparative pharmacoinformatics study.
Journal: Computers in biology and medicine
Published: September 03, 2024
Enigmatic exosomal connection in lung cancer drug resistance.
Journal: Molecular therapy. Nucleic acids
Published: April 15, 2024
Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance.
Journal: Drug discovery today
Published: February 21, 2024
Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 08, 2023
Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics.
Journal: Biotechnology journal
Published: July 27, 2023
Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer.
Journal: Archives of oral biology
Published: February 15, 2023
SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance.
Journal: Drug discovery today
Published: October 08, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026